Effect of two common GVHD prophylaxis regimens on the gut microbiome in a randomized phase 3 trial
Jakob Wirbel, Wael Saber, Michael J. Martens, Jonathan U. Peled, Tessa M. Andermann, Teng Fei, Erin F. Brooks, Boryana Doyle, Nathan B. Pincus, Robert R. Jenq, Merav Bar, Javier Bolaños-Meade, Brandi Bratrude, Saurabh Chhabra, Sung Won Choi, William Clark, Suman R. Das, Hany Elmariah, Mahasweta Gooptu, Shernan G. Holtan, Richard J. Jones, John E. Levine, Brent R. Logan, Monzr M. Al Malki, Hemant S. Murthy, Armin Rashidi, Andrew R. Rezvani, Marcie L. Riches, Lyndsey Runaas, Karamjeet Sandhu, Ashl Nature Medicine
· Springer Nature
· 2026-11-12
· DOI: 10.1038/s41591-026-04712-z
Аннотация
Nature Medicine, Published online: 12 November 2026; doi:10.1038/s41591-026-04712-z In a prespecified companion study (BMT CTN 1801) of the randomized phase 3 BMT CTN 1703 trial comparing two common GVHD prophylaxis regimens, microbiome diversity at engraftment did not associate with non-relapse mortality, but secondary analyses found baseline microbiome diversity was associated with clinical outcomes.
Jakob Wirbel, Wael Saber, Michael J. Martens, Jonathan U. Peled, Tessa M. Andermann, Teng Fei et al. Effect of two common GVHD prophylaxis regimens on the gut microbiome in a randomized phase 3 trial. // Nature Medicine. – 2026. – DOI: 10.1038/s41591-026-04712-z. – URL: https://www.nature.com/articles/s41591-026-04712-z
Jakob Wirbel, Wael Saber, Michael J. Martens, Jonathan U. Peled, Tessa M. Andermann, Teng Fei, Erin F. Brooks, Boryana Doyle, Nathan B. Pincus, Robert R. Jenq, Merav Bar, Javier Bolaños-Meade, Brandi Bratrude, Saurabh Chhabra, Sung Won Choi, William Clark, Suman R. Das, Hany Elmariah, Mahasweta Gooptu, Shernan G. Holtan, Richard J. Jones, John E. Levine, Brent R. Logan, Monzr M. Al Malki, Hemant S. Murthy, Armin Rashidi, Andrew R. Rezvani, Marcie L. Riches, Lyndsey Runaas, Karamjeet Sandhu, & Ashl (2026). Effect of two common GVHD prophylaxis regimens on the gut microbiome in a randomized phase 3 trial. Nature Medicine. https://doi.org/10.1038/s41591-026-04712-z
Jakob Wirbel, et al. “Effect of two common GVHD prophylaxis regimens on the gut microbiome in a randomized phase 3 trial.” Nature Medicine, 2026. doi:10.1038/s41591-026-04712-z.
@article{Wirbel2026,
title = {Effect of two common GVHD prophylaxis regimens on the gut microbiome in a randomized phase 3 trial},
author = {Wirbel, Jakob and Saber, Wael and Martens, Michael J. and Peled, Jonathan U. and Andermann, Tessa M. and Fei, Teng and Brooks, Erin F. and Doyle, Boryana and Pincus, Nathan B. and Jenq, Robert R. and Bar, Merav and Bolaños-Meade, Javier and Bratrude, Brandi and Chhabra, Saurabh and Choi, Sung Won and Clark, William and Das, Suman R. and Elmariah, Hany and Gooptu, Mahasweta and Holtan, Shernan G. and Jones, Richard J. and Levine, John E. and Logan, Brent R. and Malki, Monzr M. Al and Murthy, Hemant S. and Rashidi, Armin and Rezvani, Andrew R. and Riches, Marcie L. and Runaas, Lyndsey and Sandhu, Karamjeet and Ashl},
journal = {Nature Medicine},
year = {2026},
doi = {10.1038/s41591-026-04712-z},
url = {https://www.nature.com/articles/s41591-026-04712-z}
}
ABSTRACT As leadership education continues to evolve, increasing attention has been given to fostering learners’ leadership identity, capacity, and efficacy. Drawing on collaborative conversations with 12 leadership educators...